Joseph F Wayland, the Executive Vice President and* of $CB, sold 8,502 shares of the company on 07-28-2026 for an estimated $3,099,319. We received data on the trade from a recent SEC filing. This was a sale of approximately 20.1% of their shares of this class of stock. Following this trade, they now own 33,749 shares of this class of $CB stock.
$CB Insider Trading Activity
$CB insiders have traded $CB stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $CB stock by insiders over the last 6 months:
- EVAN G GREENBERG (Chairman & CEO) has made 0 purchases and 2 sales selling 29,985 shares for an estimated $9,993,140.
- JOHN W KEOGH (President &COO) has made 0 purchases and 2 sales selling 23,000 shares for an estimated $7,394,740.
- JOSEPH F WAYLAND (Executive Vice President and*) has made 0 purchases and 2 sales selling 16,147 shares for an estimated $5,671,402.
- GEORGE F. OHSIEK (Chief Accounting Officer) has made 0 purchases and 3 sales selling 5,910 shares for an estimated $1,923,106.
- JUAN LUIS ORTEGA (Executive Vice President*) sold 3,886 shares for an estimated $1,251,602
- OLIVIER STEIMER sold 2,000 shares for an estimated $658,600
- BRYCE L. JOHNS (Senior Vice President,*) sold 1,500 shares for an estimated $504,925
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$CB Hedge Fund Activity
We have seen 884 institutional investors add shares of $CB stock to their portfolio, and 875 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL WORLD INVESTORS removed 3,881,554 shares (-39.1%) from their portfolio in Q1 2026, for an estimated $1,265,114,895
- BANK OF NEW YORK MELLON CORP added 1,457,992 shares (+74.3%) to their portfolio in Q1 2026, for an estimated $475,203,332
- FMR LLC added 1,302,824 shares (+11.9%) to their portfolio in Q1 2026, for an estimated $424,629,426
- WELLINGTON MANAGEMENT GROUP LLP removed 1,200,050 shares (-16.0%) from their portfolio in Q1 2026, for an estimated $391,132,296
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 861,536 shares (+33.8%) to their portfolio in Q1 2026, for an estimated $280,800,428
- PRICE T ROWE ASSOCIATES INC /MD/ added 845,752 shares (+5.7%) to their portfolio in Q1 2026, for an estimated $275,655,949
- JONES FINANCIAL COMPANIES LLLP added 621,104 shares (+3838.5%) to their portfolio in Q1 2026, for an estimated $202,436,426
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$CB Revenue
$CB had revenues of $16B in Q2 2026. This is an increase of 7.93% from the same period in the prior year.
You can track CB financials on Quiver Quantitative's CB stock page.
You can access data on CB stock through the Quiver Quantitative API.
$CB Congressional Stock Trading
Members of Congress have traded $CB stock 4 times in the past 6 months. Of those trades, 2 have been purchases and 2 have been sales.
Here’s a breakdown of recent trading of $CB stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 05/15.
- REPRESENTATIVE JARED MOSKOWITZ purchased up to $15,000 on 03/31.
- SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
- REPRESENTATIVE THOMAS H. KEAN, JR. sold up to $50,000 on 03/26.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$CB Price Targets
Multiple analysts have issued price targets for $CB recently. We have seen 18 analysts offer price targets for $CB in the last 6 months, with a median target of $355.0.
Here are some recent targets:
- Yaron Kinar from Mizuho set a target price of $352.0 on 07/09/2026
- Ryan Tunis from Cantor Fitzgerald set a target price of $337.0 on 07/09/2026
- Elyse Greenspan from Wells Fargo set a target price of $358.0 on 07/09/2026
- Meyer Shields from Keefe, Bruyette & Woods set a target price of $389.0 on 07/08/2026
- Brian Meredith from UBS set a target price of $369.0 on 07/08/2026
- Vikram Gandhi from HSBC set a target price of $373.0 on 07/06/2026
- Bob Huang from Morgan Stanley set a target price of $340.0 on 07/06/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
